Notice: This company has been marked as potentially delisted and may not be actively trading. Flex Pharma (FLKS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends FLKS vs. TELO, NKTR, TSVT, IVA, NVCT, RENB, CRBP, MIST, VTYX, and COYAShould you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include Telomir Pharmaceuticals (TELO), Nektar Therapeutics (NKTR), 2seventy bio (TSVT), Inventiva (IVA), Nuvectis Pharma (NVCT), Renovaro (RENB), Corbus Pharmaceuticals (CRBP), Milestone Pharmaceuticals (MIST), Ventyx Biosciences (VTYX), and Coya Therapeutics (COYA). These companies are all part of the "medical" sector. Flex Pharma vs. Telomir Pharmaceuticals Nektar Therapeutics 2seventy bio Inventiva Nuvectis Pharma Renovaro Corbus Pharmaceuticals Milestone Pharmaceuticals Ventyx Biosciences Coya Therapeutics Telomir Pharmaceuticals (NASDAQ:TELO) and Flex Pharma (NASDAQ:FLKS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends, community ranking and institutional ownership. Do analysts recommend TELO or FLKS? Telomir Pharmaceuticals presently has a consensus price target of $15.00, suggesting a potential upside of 283.63%. Given Telomir Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Telomir Pharmaceuticals is more favorable than Flex Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telomir Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Flex Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer TELO or FLKS? Flex Pharma received 360 more outperform votes than Telomir Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Telomir Pharmaceuticals an outperform vote while only 73.23% of users gave Flex Pharma an outperform vote. CompanyUnderperformOutperformTelomir PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesFlex PharmaOutperform Votes36173.23% Underperform Votes13226.77% Does the media favor TELO or FLKS? In the previous week, Telomir Pharmaceuticals had 2 more articles in the media than Flex Pharma. MarketBeat recorded 2 mentions for Telomir Pharmaceuticals and 0 mentions for Flex Pharma. Telomir Pharmaceuticals' average media sentiment score of 0.40 beat Flex Pharma's score of 0.00 indicating that Telomir Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Telomir Pharmaceuticals Neutral Flex Pharma Neutral Which has preferable earnings and valuation, TELO or FLKS? Telomir Pharmaceuticals has higher earnings, but lower revenue than Flex Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelomir PharmaceuticalsN/AN/A-$16.53M-$0.58-6.74Flex Pharma$840K28.83-$21.92MN/AN/A Do insiders & institutionals believe in TELO or FLKS? 14.4% of Flex Pharma shares are owned by institutional investors. 7.6% of Flex Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is TELO or FLKS more profitable? Telomir Pharmaceuticals has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. Flex Pharma's return on equity of -98.04% beat Telomir Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Telomir PharmaceuticalsN/A -1,170.58% -832.67% Flex Pharma -1,208.42%-98.04%-83.37% SummaryTelomir Pharmaceuticals beats Flex Pharma on 8 of the 14 factors compared between the two stocks. Get Flex Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLKS vs. The Competition Export to ExcelMetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.21M$7.09B$5.83B$9.13BDividend YieldN/A2.75%4.75%3.85%P/E RatioN/A6.1426.8119.21Price / Sales28.83250.79428.3269.68Price / CashN/A65.6738.0134.83Price / Book2.636.707.644.62Net Income-$21.92M$138.98M$3.19B$246.06M Flex Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLKSFlex PharmaN/A$1.34-0.7%N/A+135.0%$24.21M$840,000.000.004TELOTelomir Pharmaceuticals2.2858 of 5 stars$4.47+2.3%N/A-56.1%$133.03MN/A-7.711Analyst ForecastNews CoverageNKTRNektar Therapeutics4.2313 of 5 stars$0.70+3.6%$4.08+483.3%+41.0%$129.12M$90.12M-0.83220News CoverageGap UpHigh Trading VolumeTSVT2seventy bio2.1828 of 5 stars$2.45+6.5%$7.20+193.9%-50.3%$126.40M$100.39M-1.32440Analyst ForecastNews CoverageIVAInventiva1.83 of 5 stars$2.37-2.4%$13.25+458.8%-16.3%$124.43M$18.91M0.00100Analyst ForecastNews CoverageGap UpNVCTNuvectis Pharma2.5695 of 5 stars$6.33-5.7%$21.00+231.8%+1.7%$122.30MN/A-5.468RENBRenovaro0.7532 of 5 stars$0.75+7.5%N/A-58.8%$119.59MN/A-0.7820Earnings ReportNews CoverageGap UpCRBPCorbus Pharmaceuticals3.9288 of 5 stars$9.78-3.6%$61.38+527.6%-67.9%$119.11MN/A-2.0940Analyst ForecastGap DownMISTMilestone Pharmaceuticals2.8057 of 5 stars$2.23+3.7%$13.00+483.0%+25.9%$118.93M$1M-2.7530VTYXVentyx Biosciences3.1176 of 5 stars$1.67-3.5%$10.00+498.8%-72.1%$118.09MN/A-0.7130Upcoming EarningsCOYACoya Therapeutics1.4304 of 5 stars$6.88+0.7%$16.25+136.2%-25.6%$114.97M$6M-10.586 Related Companies and Tools Related Companies Telomir Pharmaceuticals Competitors Nektar Therapeutics Competitors 2seventy bio Competitors Inventiva Competitors Nuvectis Pharma Competitors Renovaro Competitors Corbus Pharmaceuticals Competitors Milestone Pharmaceuticals Competitors Ventyx Biosciences Competitors Coya Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FLKS) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredA new coin is elbowing its way to the top of the crypto worldWith Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FLKS Stock Alerts